Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemial

Sabina Kersting,Mark-David Levin,Martine E.D. Chamuleau,Simon Daenen,E Dompeling,Jeanette K. Doorduijn,M. van Gelder,Mels Hoogendoorn,J. M. Kerst,Marcel Nijland,Marten Nijziel,E.F. Posthuma,Reinier Raymakers,M. R. Schaafsma,M. H. Silbermann,H.M. van der Straaten,J. H. Veelken,Josephine M. Vos,S. Wittebol,M. H. J. Van Oers,Arnon P. Kater

Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemial

2016

In recent years, considerable progress has been made in the treatment of patients with chronic lymphocytic leukaemia (CLL). Therefore, the CLL working group of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) framework revised the Dutch guidelines based on new studies and expert opinion of members of the working group

Keywords:

Diabetes mellitus
Endocrinology
Rituximab
Immunology
Leukemia
Lymphocytic leukaemia
Internal medicine
Alemtuzumab
Cyclophosphamide
Medicine
Fludarabine
expert opinion

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations